Junshi Bio issues proxy form for 2025 AGM; agenda covers profit distribution, financing mandates and INED election

Bulletin Express06-05

Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) has released the proxy form for its 2025 Annual General Meeting, to be held on 26 June 2026 at 2:30 p.m. on the 15th Floor, Building 7, No. 6, Lane 100, Pingjiaqiao Road, Pudong New Area, Shanghai.

Shareholders will vote on 11 ordinary resolutions: 1) the 2025 Board report; 2) the 2025 annual report and summary; 3) the 2025 profit distribution plan; 4) approval of 2026 financing and credit lines from financial institutions; 5) director remuneration for 2026; 6) appointment of both PRC and overseas auditors for 2026; 7) formulation of remuneration policies for directors and senior management; 8) a three-year (2026–2028) dividend distribution plan; 9) election of an independent non-executive director for the fourth board session; 10) equity changes in entities executing certain investment sub-projects; 11) an external investment and connected transaction.

Three special resolutions are also proposed: 12) an estimated external guarantee quota for 2026; 13) a general mandate to issue domestic and/or overseas debt-financing instruments; 14) a general mandate to issue additional A Shares and/or H Shares.

The proxy form must be lodged with the H-share registrar, Tricor Investor Services Limited, no later than 24 hours before the meeting. Completion of the proxy does not preclude shareholders from attending and voting in person.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1169733289?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-05 23:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169733289","market":"us","top_or_hot":-1,"title":"Junshi Bio issues proxy form for 2025 AGM; agenda covers profit distribution, financing mandates and INED election","media":"Bulletin Express","content":"<p>Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) has released the proxy form for its 2025 Annual General Meeting, to be held on 26 June 2026 at 2:30 p.m. on the 15th Floor, Building 7, No. 6, Lane 100, Pingjiaqiao Road, Pudong New Area, Shanghai.</p>\n<p>Shareholders will vote on 11 ordinary resolutions:\n1) the 2025 Board report;  \n2) the 2025 annual report and summary;  \n3) the 2025 profit distribution plan;  \n4) approval of 2026 financing and credit lines from financial institutions;  \n5) director remuneration for 2026;  \n6) appointment of both PRC and overseas auditors for 2026;  \n7) formulation of remuneration policies for directors and senior management;  \n8) a three-year (2026–2028) dividend distribution plan;  \n9) election of an independent non-executive director for the fourth board session;  \n10) equity changes in entities executing certain investment sub-projects;  \n11) an external investment and connected transaction.</p>\n<p>Three special resolutions are also proposed:\n12) an estimated external guarantee quota for 2026;  \n13) a general mandate to issue domestic and/or overseas debt-financing instruments;  \n14) a general mandate to issue additional A Shares and/or H Shares.</p>\n<p>The proxy form must be lodged with the H-share registrar, Tricor Investor Services Limited, no later than 24 hours before the meeting. Completion of the proxy does not preclude shareholders from attending and voting in person.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Junshi Bio issues proxy form for 2025 AGM; agenda covers profit distribution, financing mandates and INED election</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJunshi Bio issues proxy form for 2025 AGM; agenda covers profit distribution, financing mandates and INED election\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-05 23:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) has released the proxy form for its 2025 Annual General Meeting, to be held on 26 June 2026 at 2:30 p.m. on the 15th Floor, Building 7, No. 6, Lane 100, Pingjiaqiao Road, Pudong New Area, Shanghai.</p>\n<p>Shareholders will vote on 11 ordinary resolutions:\n1) the 2025 Board report;  \n2) the 2025 annual report and summary;  \n3) the 2025 profit distribution plan;  \n4) approval of 2026 financing and credit lines from financial institutions;  \n5) director remuneration for 2026;  \n6) appointment of both PRC and overseas auditors for 2026;  \n7) formulation of remuneration policies for directors and senior management;  \n8) a three-year (2026–2028) dividend distribution plan;  \n9) election of an independent non-executive director for the fourth board session;  \n10) equity changes in entities executing certain investment sub-projects;  \n11) an external investment and connected transaction.</p>\n<p>Three special resolutions are also proposed:\n12) an estimated external guarantee quota for 2026;  \n13) a general mandate to issue domestic and/or overseas debt-financing instruments;  \n14) a general mandate to issue additional A Shares and/or H Shares.</p>\n<p>The proxy form must be lodged with the H-share registrar, Tricor Investor Services Limited, no later than 24 hours before the meeting. Completion of the proxy does not preclude shareholders from attending and voting in person.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01877","symbol_name":"君实生物","start_time":0,"source_url":"","article_id":"1169733289","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169733289","pubTimestamp":1780671798,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) has released the proxy form for its 2025 Annual General Meeting, to be held on 26 June 2026 at 2:30 p.m. on the 15th Floor, Building 7, No. 6, Lane...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01877":"君实生物"},"translate_title":"君实生物发出2025年股东周年大会代表委任表格；议程包括利润分配、融资授权及独立非执行董事选举","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01877":1},"content_text":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) has released the proxy form for its 2025 Annual General Meeting, to be held on 26 June 2026 at 2:30 p.m. on the 15th Floor, Building 7, No. 6, Lane 100, Pingjiaqiao Road, Pudong New Area, Shanghai.\nShareholders will vote on 11 ordinary resolutions:\n1) the 2025 Board report;  \n2) the 2025 annual report and summary;  \n3) the 2025 profit distribution plan;  \n4) approval of 2026 financing and credit lines from financial institutions;  \n5) director remuneration for 2026;  \n6) appointment of both PRC and overseas auditors for 2026;  \n7) formulation of remuneration policies for directors and senior management;  \n8) a three-year (2026–2028) dividend distribution plan;  \n9) election of an independent non-executive director for the fourth board session;  \n10) equity changes in entities executing certain investment sub-projects;  \n11) an external investment and connected transaction.\nThree special resolutions are also proposed:\n12) an estimated external guarantee quota for 2026;  \n13) a general mandate to issue domestic and/or overseas debt-financing instruments;  \n14) a general mandate to issue additional A Shares and/or H Shares.\nThe proxy form must be lodged with the H-share registrar, Tricor Investor Services Limited, no later than 24 hours before the meeting. Completion of the proxy does not preclude shareholders from attending and voting in person.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1169733289","isCrawlerRequest":true}